CTI acquires CRO based in Middle East, Africa

By Jenni Spinner contact

- Last updated on GMT

(AnnaStills/iStock via Getty Images Plus)
(AnnaStills/iStock via Getty Images Plus)

Related tags: Contract research organization, Cti clinical trial, acquisition, Middle east, Africa

CTI Clinical Trial and Consulting Services has expanded its global reach by purchasing Clinart, a full-service CRO with precence in the MENA region.

Kentucky-based contract research organization (CRO) CTI, with locations around the world, has extended its reach into the Middle East/northern Africa (MENA) region, with associates in Egypt, Morocco, Saudia Arabia and other countries in the area. Former Clinart CEO Alaa Assem will now act as CTI’s managing director for the MENA region.

Patrick Earley, CTI chief international business offer, commented that the acquisition of Clinart will increase the company’s reach for its clients around the world.

We are excited to have Clinart join CTI to create a stronger and more robust global full-service CRO​,” Earley commented. “This acquisition has been in the works for quite some time, and despite the global crises we’re currently experiencing, we felt passionately about moving this deal forward for the future success of our organization. In fact, this merger will allow both companies to continue and expand the global reach of their important work in COVID-19 research​.”

Assem commented, “Joining CTI allows for our clients to have expanded industry leading therapeutic expertise, a broader global footprint, and a greater capacity for innovative solutions. Our employees have been key to our success in the region the last two decades, and they will continue to use their local expertise to support CTI’s growth and projects​.”

CTI, its third decade, is one of the 20 largest CROs in the world, with associates in more than 60 countries. The company currently manages more than 20 active COVID-19 trials for treatment and prevention solutions; it also is conducting projects involving regenerative medicine, rare diseases and other therapeutic indications.

In July, CTI announced a collaboration with clinical trial support specialist Medidata​. The partnership will put in place technology designed to facilitate remote monitoring and review of documents for COVID-19 research and other studies.

Related news

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Related suppliers

Follow us

Products

View more

Webinars